ZTEK Stock Summary and Trading Ideas (Zentek Ltd. | NASDAQ:ZTEK)

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Zentek Ltd. trades on the NASDAQ stock market under the symbol ZTEK.

As of June 18, 2026, ZTEK stock price declined to $0.41 with 288,528 million shares trading.

ZTEK has a beta of 1.31, meaning it tends to be more sensitive to market movements. ZTEK has a correlation of 0.04 to the broad based SPY ETF.

ZTEK has a market cap of $44.40 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ZTEK traded as high as $1.84 and as low as $.40.

ZTEK has underperformed the market in the last year with a price return of -69.6% while the SPY ETF gained +26.9%. ZTEK has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.5% and -21.8%, respectively, while the SPY returned +13.5% and -1.1%, respectively.

ZTEK support price is $.41 and resistance is $.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZTEK shares will trade within this expected range on the day.